AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Alnylam Pharmaceuticals, Inc.
€207.2
-$132.50 (-39.01%)
XETRA · 16 Sep 2026 07:04 UTC
Previous Close
€210.4
Day Range
€207.2 - €207.2
Year Range
€177.1€407.5
Market Cap
27.73B
AVG Volume
140
Trailing/Forward PE
39.06/20.88
PEG ratio
0.77
Dividend Yield
-
Next Earnings Date
2026-10-29
Primary Exchange
Deutsche Börse
Video analysis: DUL.DE
All videosNo video analysis for this stock yet. Request one from our team.
Similar companies
-
Siemens Healthineers AG
SHL.DE
·
Deutsche Börse
Compare
-
Merck KGaA
MRK.DE
·
Deutsche Börse
Compare
-
Zoetis Inc.
ZOE.DE
·
Deutsche Börse
Compare
-
BioNTech SE
22UA.F
·
Frankfurt Stock Exchange
Compare
-
Veeva Systems Inc.
VEE.DE
·
Deutsche Börse
Compare
-
Vertex Pharmaceuticals Incorporated
VX1.DE
·
Deutsche Börse
Compare